In this regard, we examined the association between ATAD2 expression and patients outcome and discovered that high level of ATAD2 was significantly correlated with poor overall survival of ESCC patients especially those with advanced stage. The gene discussed is ATAD2; the disease is esophageal squamous cell carcinoma.